The American Association for the Treatment of Opioid Dependence works with federal and state agency officials concerning opioid treatment policy throughout the United States. Their website provides access to resources, trainings, and webinars.
Treatment Resources
- Medical
The American Society of Addiction Medicine is a professional medical society in the field of addiction medicine. Their website contains educational resources and policy advocacy resources and toolkits.
- Advocates / Peers
- Community Coalitions
- Medical
This is a perspective academic article on the intersection of the opioid crisis and the coronavirus pandemic written by expert researchers, with a focus on treatment access for medications for opioid use disorder (MOUD).
- COVID / Coronavirus related
- Policymakers
This is a report that provides an update on the Trump Administration's Commission on Combating Drug Addiction and the Opioid Crisis, which includes progress made on the initial 56 recommendations made by the Commission.
- Educational
- Addiction Treatment Providers
- Community Health Officials
- Criminal Justice
- Policymakers
This guide provides practical approaches to prevent addiction-related stigma. These range from simple efforts, such as writing letters to the editor, to more complex efforts, such as implementing community-based stigma prevention campaigns.
- Educational
- Advocates / Peers
- Community Coalitions
- Community Health Officials
- Harm Reduction Specialists
- Medical
- Policymakers
This is a report from the O’Neill Institute for National and Global Health Law at Georgetown Law Center (authors LaBelle and Weizman) that provides recommendations for actions that state and local leaders can take immediately to increase evidence-based practices, decrease arbitrary determinations, and prevent overdose deaths in criminal justice and child welfare settings. Multiple case studies are highlighted.
- Family Support
- Medications for Opioid Use Disorder
- Community Coalitions
- Community Health Officials
- Criminal Justice
- Law Enforcement
- Policymakers
This is an academic paper that examined initiation of medications for opioid use disorder (MOUD) based on waiting time for an appointment at a low threshold addiction clinic in Boston. Patients who were able to get same-day or next-day appointments were more likely to arrive at their appointments compared with those who had to wait longer. This finding highlights that hospitals should have immediate access to MOUD, such as access a bridge clinic co-located at the hospital, to increase engagement in MOUD.
- Medications for Opioid Use Disorder
- Addiction Treatment Providers
- Community Health Officials
- Health Insurers
- Hospitals
- Medical
- Policymakers
This is a report from the National Endowment for the Arts that describes the evidence on the role of the arts in the management of pain and in the prevention and treatment of substance use disorders. Evidence for art-based therapies, especially music, is promising and also includes painting, literature, and dance.
- Early Intervention
- Educational
- Addiction Treatment Providers
- Community Coalitions
The American Society of Addiction Medicine (ASAM) Coronavirus resource page provides information on the addiction treatment system during the Covid pandemic, including guidance to treatment providers, addiction treatment professionals, and accessing medications for opioid use disorder.
- COVID / Coronavirus related
- Medications for Opioid Use Disorder
- Addiction Treatment Providers
- Community Health Officials
- Medical
- Policymakers
This website provides a report and other resources from the Association of Schools and Programs in Public Health (ASSPH) that makes research-informed recommendations across the entire continuum of care to address the opioid crisis.
- Comprehensive services
- Educational
- Medications for Opioid Use Disorder
- Overdose prevention
- Syringe service program / Needle exchange
- Addiction Treatment Providers
- Community Coalitions
- Community Health Officials
- Harm Reduction Specialists
- Medical
- Policymakers
This academic paper provides a summary on state-level policy data relevant to opioid use disorder treament reported by government and non profit agencies that track healthcare regulations. The four areas this report focuses on are tele-health, privacy, licensing, and medication for opioid use disorder (MOUD) during the COVID-19 pandemic.
- COVID / Coronavirus related
- Medications for Opioid Use Disorder
- Addiction Treatment Providers
- Policymakers
This is an academic paper that explores how methadone and buprenorphine capacity vary by race/ethnicity. Study findings show that counties with highly segregated black/African American and Hispanic/Latinx communities had more facilities to provide methadone per capita, while counties with highly segregated white communities had more facilities to provide buprenorphine per capita, highlighting the need for racial equity and justice.
- Medications for Opioid Use Disorder
- Addiction Treatment Providers
- Community Coalitions
- Community Health Officials
- Hospitals
- Medical
- Policymakers